Ra Capital Management, L.P. Eliem Therapeutics, Inc. Call Options Transaction History
Ra Capital Management, L.P.
- $5.82 Billion
- Q3 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ELYM
# of Institutions
67Shares Held
44.3MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA1.32MShares$5.41 Million0.0% of portfolio
-
Affinity Asset Advisors, LLC New York, NY1.3MShares$5.34 Million0.62% of portfolio
-
Kynam Capital Management, LP Princeton, NJ1.03MShares$4.23 Million0.36% of portfolio
-
Tang Capital Management LLC San Diego, CA1MShares$4.11 Million0.19% of portfolio
-
Peapod Lane Capital LLC Bedford Hills, NY562KShares$2.31 Million1.01% of portfolio
About Eliem Therapeutics, Inc.
- Ticker ELYM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,567,700
- Market Cap $109M
- Description
- Eliem Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapies for neuronal excitability disorders to address unmet needs in chronic pain, neuropsychiatry, epilepsy, and other disorders of the peripheral and central nervous systems. Its two lead drug candidates are ETX-810 for chronic pain, which is in Phase II...